title: Vortioxetine hydrobromide, crofelemer, and teduglutide.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Angela
authors.initials: A
authors.lastname: Lye
mesh_terms: D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy; D006801:Humans; D010455:Peptides / Q000009:adverse effects / Q000627:therapeutic use*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D044945:Proanthocyanidins / Q000009:adverse effects / Q000627:therapeutic use*; D013440:Sulfides / Q000009:adverse effects / Q000627:therapeutic use*; D000078784:Vortioxetine
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D010455:Peptides; D010879:Piperazines; D044945:Proanthocyanidins; D013440:Sulfides; D000078784:Vortioxetine; C494910:teduglutide; C546704:crofelemer